Cleveland Clinic and G42 join forces to drive AI-Powered healthcare innovation

Cleveland Clinic and G42 have entered into a strategic collaboration to advance the adoption of artificial intelligence (AI) in healthcare, marking yet another major step in realizing AI’s potential in medicine. The partnership will create a joint task force to assess, prioritize, and expedite AI-powered efforts to enhance patient care, medical research, and operational efficiency.

G42, based in Abu Dhabi, UAE, is a global technology pioneer specializing in AI, digital infrastructure, and big data analytics. M42, the group’s healthcare subsidiary, operates 480 clinics in 26 countries and has led large health projects such as the Emirati Genome Program and Abu Dhabi’s health information exchange, Malaffi.

“Cleveland Clinic is committed to finding opportunities that improve patient safety, patient experience, patient outcomes, and access,” said Cleveland Clinic CEO and President Tom Mihaljevic, M.D. “Artificial intelligence offers a tremendous opportunity to continue to advance and fulfill our mission of caring for life, researching for health, and educating those who serve.”

This collaboration will explore and implement transformative AI initiatives aimed at redefining patient care, enhancing medical innovation, and optimizing hospital operations. These AI-powered advancements will have a far-reaching impact, benefiting not only the UAE and surrounding regions but also shaping the future of global healthcare.

“AI’s potential to transform the healthcare industry remains largely untapped,” said Peng Xiao, Group CEO of G42. “From deciphering the source code of life – our genome – to optimizing efficiencies across the entire patient journey, AI is paving the way for a future where care is not only more precise but also deeply personalized and preventative. We look forward to embarking on this journey alongside Cleveland Clinic and other global partners, harnessing AI to unlock new frontiers in medicine, empower clinicians with unprecedented insights, and ultimately reshape the way humanity experiences health and longevity.”

This partnership is bolstered by Cleveland Clinic’s reputation as a top innovator in medicine. For the seventh straight year, Newsweek’s World’s Best Hospitals 2025 list has ranked the institution the No. 2 hospital in the world. The organization has a history of being at the forefront of medical advances, such as coronary artery bypass surgery, deep brain stimulation surgery, and the first face transplant in the United States. In 2023, Cleveland Clinic became home to the world’s first quantum computer dedicated to healthcare research—IBM Quantum System One—designed to accelerate biomedical discoveries.

This partnership between Cleveland Clinic and G42 marks a significant step toward the future of AI-powered healthcare. By leveraging intelligent, data-driven solutions, the two organizations are set to revolutionize patient care, medical research, and healthcare delivery on a global scale.